Concepedia

Author

Kristian Friedrich

GlaxoSmithKline (United States)ORCID

Also Known As

K. J. Friedrich, Kristian Friedrich

7

Publications

251

Citations

6

H-Index

21

Concepts

All Affiliations

GlaxoSmithKline (United States)Novartis (United States)
KF

About

Kristian Friedrich is an author at GlaxoSmithKline (United States) specializing in medicine, vaccination, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

111

2

Immunology

3

3

111

3

Natural Sciences

1

1

14

4

Allergy

1

1

22

5

Cell Biology

1

1

75

Kristian Friedrich

×

6

Publications

251

Citations

6

H-Index

YearCitations

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models

Giulietta Maruggi, Corey P. Mallett, Jason W. Westerbeck,

Molecular Therapy

2022

80

Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies

Claudio Ciferri, Sumana Chandramouli, Alexander Leitner,

PLoS Pathogens

2015

75

Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV

Ann‐Muriel Steff, James E. Monroe, Kristian Friedrich,

Nature Communications

2017

39

Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine

Rushit N. Lodaya, Amey P. Kanitkar, Kristian Friedrich,

Journal of Controlled Release

2019

22

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant

Yingxia Wen, Hung V. Trinh, Christine Linton,

PLoS ONE

2018

21

Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F

Wayne Harshbarger, Sai Tian, Newton Wahome,

PLoS Pathogens

2020

14

Page 1